Evidence map›Paper›PMID 34065660›Full record

ReviewPharmaceutics2021

Seaweed Sulfated Polysaccharides against Respiratory Viral Infections.

Mehwish Jabeen, Mélody Dutot, Roxane Fagon, Bernard Verrier, Claire Monge

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. From Ocean to Medicine: Harnessing Seaweed's Potential for Drug Development.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Luminescent polyelectrolytes with antiviral activity.Russian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mehwish JabeenLaboratory of Tissue Biology and Therapeutic Engineering, UMR5305 Centre National de la Recherche Scientifique/Université Claude Bernard Lyon 1, 7 Passage du Vercors, CEDEX 07, 69367 Lyon, France.
Mélody DutotRecherche & Développement, Yslab, 29000 Quimper, France.ORCID 0000-0003-0964-0664
Roxane FagonRecherche & Développement, Yslab, 29000 Quimper, France.
Bernard VerrierLaboratory of Tissue Biology and Therapeutic Engineering, UMR5305 Centre National de la Recherche Scientifique/Université Claude Bernard Lyon 1, 7 Passage du Vercors, CEDEX 07, 69367 Lyon, France.
Claire MongeLaboratory of Tissue Biology and Therapeutic Engineering, UMR5305 Centre National de la Recherche Scientifique/Université Claude Bernard Lyon 1, 7 Passage du Vercors, CEDEX 07, 69367 Lyon, France.ORCID 0000-0001-6715-2226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory viral infections have been a leading cause of morbidity and mortality worldwide. Despite massive advancements in the virology field, no specific treatment exists for most respiratory viral infections. Approved therapies against respiratory viruses rely almost exclusively on synthetic drugs that have potential side effects, restricting their use. This review aims to present natural marine sulfated polysaccharides possessing promising antiviral activity against respiratory viruses that could be a safe alternative to synthetic broad-spectrum antiviral drugs. The antiviral properties of marine sulfated polysaccharides are presented according to their mechanism of action on different types and strains of respiratory viruses, and the potential limits of their use are discussed.

Indexed as

antiviral activityapproved antiviralsmechanism of actionrespiratory virusseaweedsulfated polysaccharide

Identifiers

PMID34065660
PMCPMC8156470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.